Following announced funding freeze, White House confirms Medicaid portals are down

Multiple reports, spurred by statements made by lawmakers on X/Twitter, have claimed that Medicaid portals across the country were shut down, leaving patients and providers in limbo.

Sen. Ron Wyden (D-OR) was the first to make the claim, citing “numerous sources” who told his office that Medicaid portals were down in all 50 states. Wyden followed up with another post shortly after, saying his staff had confirmed the outages.

More Democratic Senators would soon comment on the Medicaid systems being down in their respective states, including Brian Schatz of Hawaii and Chris Murphy of Connecticut. Murphy said the outage was affecting payment systems in his state, adding that “doctors and hospitals can’t get paid.”

The outage followed a Tuesday memo from the White House calling for a freeze on funds for federal aid programs. Neither the White House nor the U.S. Department of Health and Human Services (HHS) had announced an outage prior to it happening. However, it was later confirmed, though no explanation was provided.

“The White House is aware of the Medicaid website portal outage,” White House press secretary Karoline Leavitt said in a post on X/Twitter, denying that payments were affected.

"We have confirmed that no payments have been affected—they are still being processed and sent. We expect the portal will be back online shortly," she added.

It remains unclear what spurred the portal downtime, how long it lasted and which systems were impacted. There are no reports of Medicare reimbursement being halted, and the issue seems to be limited to state Medicaid programs. 

This is a developing story.

HealthExec reached out to multiple hospitals for comment but has yet to receive a reply. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.

The ACC, AHA, HFSA, HRS and SCAI all worked together to try and make the new board a reality. Though their proposal has been denied, the groups say they are not done fighting. 

The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.